251
Participants
Start Date
September 16, 2005
Primary Completion Date
October 14, 2011
Study Completion Date
September 30, 2028
Low-dose computed tomography (LDCT)
"In phase A of the study, patients will undergo conventional CT along with low dose CT. If patients have a normal conventional CT and a satisfactory low dose CT, they will move onto Phase B of the study in which they will undergo surveillance using low-dose CT. Three outcomes are possible with low-dose CT surveillance:~1. Normal LDCT:~ \- Patient continues on the study (i.e. continued surveillance)~2. Suspicious LDCT:~ \- Will undergo conventional CT and if results are normal, patient will continue on study. If conventional CT is abnormal, they will be taken off study~3. Elevated serum tumour markers or other evidence of metastatic disease:~ * Patient goes off study"
University Health Network, Princess Margaret Hospital, Toronto
University Health Network, Toronto
OTHER